Key Viral Hepatitis Studies From AASLD 2021

Source: Clinical Impact of New Viral Hepatitis Data From AASLD 2021*

November 12-15, 2021; Virtual

Read expert faculty members’ summaries of HBV, HCV, and hepatitis delta virus (HDV), including data on HBV therapy during pregnancy, outcomes following treatment withdrawal in HBV, progress toward an HBV cure, HDV clinical impact and phase III clinical trial updates, and HCV implementation science and current status of the cascade of care.

Nancy Reau, MD

Stefan Zeuzem, MD

Format: Microsoft PowerPoint (.ppt)

File Size: 323 KB

Released: November 29, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from

AbbVie
Gilead Sciences, Inc.

Key Viral Hepatitis Studies From AASLD 2021

Acknowledgements

Leaving the CCO site